ARCHITECT CA 19-9XR
Report
- Report Number
- 1415939-2014-00164
- Event Type
- Malfunction
- Date Received
- July 22, 2014
- Date of Event
- June 30, 2014
- Report Date
- June 30, 2014
- Manufacturer
- ABBOTT LABORATORIES
- Product Code
- NIG
- PMA / PMN Number
- K052000
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- OTHER
Narratives
(B)(4). AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 2K91-25 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 2K91-27.
THE CUSTOMER OBSERVED A FALSELY ELEVATED ARCHITECT CA 19-9XR RESULT ON A PATIENT THAT HAD PREVIOUSLY BEEN LOWER. ACCURACY TESTING WAS COMPLETED USING RETAINED KITS OF REAGENT LOT 33394M500. ACCEPTANCE CRITERIA WERE MET, WHICH INDICATES ACCEPTABLE PRODUCT PERFORMANCE. THE ARCHITECT CA 19-9XR REAGENT PACKAGE INSERT WAS REVIEWED AND WAS FOUND TO ADEQUATELY ADDRESS THE ISSUE. THE INVESTIGATION DID NOT IDENTIFY A MALFUNCTION / DEFICIENCY.
THE CUSTOMER STATED THAT A FALSELY ELEVATED ARCHITECT CA 19-9 RESULT WAS GENERATED ON A PATIENT THAT PREVIOUSLY HAD BEEN LOWER. ON (B)(6) 2014 AN INITIAL RESULT OF 66.92 U/ML WAS GENERATED. THE SAMPLE WAS REPEATED WITH RESULTS OF 3.4 AND 5.06 U/ML. IN (B)(6) THE PATIENT HAD A RESULT OF 6 U/ML. THERE WAS NO REPORT OF IMPACT TO PATIENT MANAGEMENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 428737 | ARCHITECT CA 19-9XR | CA 19-9 | NIG | ABBOTT LABORATORIES | 33394M500 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | SN (B)(4)| ARCHITECT I2000SR ANALYZER 03M74-01| ARCHITECT I2000SR ANALYZER 03M74-01| SN (B)(4) |